Literature DB >> 11940907

ECT in the Treatment of Organic Psychosis in Huntington's Disease.

Dwight L. Evans1, Cort A. Pedersen, Manuel E. Tancer.   

Abstract

Huntington's disease (HD) is a progressive neurological disorder characterized by choreiform movements, dementia, and psychiatric symptoms. The psychiatric symptoms often lead to long-term psychiatric hospitalization. We report the case of a 49-year-old woman with HD of 1 year's duration who presented with an organic psychotic syndrome with voices telling her to kill herself or her children. The psychosis was refractory to neuroleptic treatment (up to 1,250 mg chlorpromazine equivalents per day). Depressive symptoms emerged but were neither of a magnitude nor of a duration to suggest a major affective disorder. Nonetheless, we treated the patient empirically with antidepressants, which had to be discontinued because of symptomatic orthostatic hypotension. Based on the persistent psychosis with suicidal and homicidal ideation and possible long-term state psychiatric hospitalization, we recommended electroconvulsive therapy (ECT). ECT was successful in treating the psychosis as well as the depressive symptoms. There was no worsening of the patient's dementia and only a slight progression in her choreiform movements. The authors question whether ECT may be of benefit in treating the psychosis of HD in the presence or absence of depressive symptoms and call for further research to determine if the use of ECT in HD patients with psychosis could prevent, or at least delay, placement in a long-term psychiatric hospital.

Entities:  

Year:  1987        PMID: 11940907

Source DB:  PubMed          Journal:  Convuls Ther        ISSN: 0749-8055


  5 in total

1.  Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease.

Authors:  Takeshi Nakano; Shinji Ono; Junji Yamaguchi; Ryu Sugimoto; Naohiro Yamaguchi; Yoshiro Morimoto; Tatsuya Kubo; Hiroki Ozawa; Naohiro Kurotaki
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

Review 2.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

3.  Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

Authors:  Mohamed R Mughal; Akanksha Baharani; Srinivasulu Chigurupati; Tae Gen Son; Edmund Chen; Peter Yang; Eitan Okun; Thiruma Arumugam; Sic L Chan; Mark P Mattson
Journal:  Hum Mol Genet       Date:  2010-11-24       Impact factor: 6.150

4.  International Guidelines for the Treatment of Huntington's Disease.

Authors:  Anne-Catherine Bachoud-Lévi; Joaquim Ferreira; Renaud Massart; Katia Youssov; Anne Rosser; Monica Busse; David Craufurd; Ralf Reilmann; Giuseppe De Michele; Daniela Rae; Ferdinando Squitieri; Klaus Seppi; Charles Perrine; Clarisse Scherer-Gagou; Olivier Audrey; Christophe Verny; Jean-Marc Burgunder
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.086

5.  Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.

Authors:  Walied Mowafi; Jon Millard
Journal:  BJPsych Bull       Date:  2021-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.